Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Elena García-Taboada"'
Autor:
José Aguareles, Juan Paraíso-Luna, Belén Palomares, Raquel Bajo-Grañeras, Carmen Navarrete, Andrea Ruiz-Calvo, Daniel García-Rincón, Elena García-Taboada, Manuel Guzmán, Eduardo Muñoz, Ismael Galve-Roperh
Publikováno v:
Translational Neurodegeneration, Vol 8, Iss 1, Pp 1-15 (2019)
Abstract Background The administration of certain cannabinoids provides neuroprotection in models of neurodegenerative diseases by acting through various cellular and molecular mechanisms. Many cannabinoid actions in the nervous system are mediated b
Externí odkaz:
https://doaj.org/article/06f670319187485080ac1fedb5b6f158
Autor:
Dolores Hernán Pérez de la Ossa, Mar Lorente, Maria Esther Gil-Alegre, Sofía Torres, Elena García-Taboada, María Del Rosario Aberturas, Jesús Molpeceres, Guillermo Velasco, Ana Isabel Torres-Suárez
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e54795 (2013)
Cannabinoids, the active components of marijuana and their derivatives, are currently investigated due to their potential therapeutic application for the management of many different diseases, including cancer. Specifically, Δ(9)-Tetrahydrocannabino
Externí odkaz:
https://doaj.org/article/6f8660403bff488cbb3d7be0f6be1e43
Autor:
Guillermo Velasco, Manuel Guzmán, Juan Barcia, Elena García-Taboada, María Salazar, Sonia Hernández-Tiedra, Fátima Rodríguez-Fornés, Mar Lorente, Sofía Torres
Supplementary Table 1 from A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8620ea7a99f71cb308fe901bd1d0432a
https://doi.org/10.1158/1535-7163.22497057
https://doi.org/10.1158/1535-7163.22497057
Autor:
Guillermo Velasco, Manuel Guzmán, Juan Barcia, Elena García-Taboada, María Salazar, Sonia Hernández-Tiedra, Fátima Rodríguez-Fornés, Mar Lorente, Sofía Torres
Supplementary Figures 1-11 from A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::809dec2fd849d2e32e34ae12e713c988
https://doi.org/10.1158/1535-7163.22497060.v1
https://doi.org/10.1158/1535-7163.22497060.v1
Autor:
Manuel Moreno-Valladares, Marina Mendiburu-Eliçabe, Alberto Ocaña, Alba Orea-Soufi, Nélida Salvador-Tormo, Paola Martín-Cabrera, Guillermo Velasco, Estibaliz Gabicagogeascoa, Mar Lorente, Francisco J. Cimas, Silvia Iglesias Recuero, Ander Matheu, José Miguel Ramos-Pittol, Isabel Álvarez-López, Sonia Castillo-Lluva, Elena García-Taboada, Adrián Blanco-Gómez
Publikováno v:
Cancers, Vol 13, Iss 5307, p 5307 (2021)
Cancers
Volume 13
Issue 21
Digital.CSIC. Repositorio Institucional del CSIC
instname
E-Prints Complutense. Archivo Institucional de la UCM
Cancers
Volume 13
Issue 21
Digital.CSIC. Repositorio Institucional del CSIC
instname
E-Prints Complutense. Archivo Institucional de la UCM
© 2021 by the authors.
[Background]: Tribbles pseudokinase 3 (TRIB3) has been proposed to both promote and restrict cancer generation and progression. However, the precise mechanisms that determine this dual role of TRIB3 in cancer remain to be
[Background]: Tribbles pseudokinase 3 (TRIB3) has been proposed to both promote and restrict cancer generation and progression. However, the precise mechanisms that determine this dual role of TRIB3 in cancer remain to be
Autor:
Raquel Bajo-Grañeras, Silvia Ortega-Gutiérrez, Rudolf Zechner, Irene B. Maroto, Andrea Ruiz-Calvo, Debora Zian, Eva Resel, Luigi Bellocchio, Manuel Guzmán, Robert Zimmermann, Elena García-Taboada, Gernot F. Grabner, Ismael Galve-Roperh
Publikováno v:
Neuropharmacology. 150:134-144
Cannabinoids exert neuroprotection in a wide array of preclinical models. A number of these studies has focused on cannabinoid CB1 receptors in striatal medium spiny neurons (MSNs) and the most characteristic MSN-degenerative disease, Huntington's di
Autor:
Manuel Guzmán, Sonia Hernández-Tiedra, María Salazar-Roa, Guillermo Velasco, Juan Manuel Sepúlveda, Mar Lorente, Elena García-Taboada, Israel López-Valero, Sofia Torres
Publikováno v:
Biochemical Pharmacology. 157:275-284
Glioblastoma multiforme (GBM) is the most frequent and aggressive form of brain cancer. These features are explained at least in part by the high resistance exhibited by these tumors to current anticancer therapies. Thus, the development of novel the
Autor:
Mara Gordon, Jeff Wade, Miriam Caro-Villalobos, Isabel Tundidor, Clara Andradas, Marta Seijo-Vila, Elena García-Taboada, Manuel Guzmán, Sandra Blasco-Benito, Stewart Smith, Cristina Sánchez, Eduardo Pérez-Gómez
Publikováno v:
Biochemical Pharmacology. 157:285-293
Breast cancer is the second leading cause of death among women. Although early diagnosis and development of new treatments have improved their prognosis, many patients present innate or acquired resistance to current therapies. New therapeutic approa
Autor:
Javier Díaz-Alonso, Juan Paraíso-Luna, Samuel Simón-Sánchez, Ane Cristina Ayo-Martin, Silvia Cappello, José Sánchez-Prieto, Daniel García-Rincón, Ricardo Martín, José Aguareles, Carlos Costas-Insua, Isabel Liste, Adán de Salas-Quiroga, Ismael Galve-Roperh, Elena García-Taboada, Manuel Guzmán
Publikováno v:
Repisalud
Instituto de Salud Carlos III (ISCIII)
Instituto de Salud Carlos III (ISCIII)
The endocannabinoid (eCB) system, via the cannabinoid CB1 receptor, regulates neurodevelopment by controlling neural progenitor proliferation and neurogenesis. CB1 receptor signalling in vivo drives corticofugal deep layer projection neuron developme
Autor:
Juan, Paraíso-Luna, José, Aguareles, Ricardo, Martín, Ane C, Ayo-Martín, Samuel, Simón-Sánchez, Daniel, García-Rincón, Carlos, Costas-Insua, Elena, García-Taboada, Adán, de Salas-Quiroga, Javier, Díaz-Alonso, Isabel, Liste, José, Sánchez-Prieto, Silvia, Cappello, Manuel, Guzmán, Ismael, Galve-Roperh
Publikováno v:
Development (Cambridge, England). 147(24)
The endocannabinoid (eCB) system, via the cannabinoid CB